TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmetheus AB
Closing information (x1000 NOK)
Closing information | 2023/11 | 2022/11 | 2021/11 |
Turnover |
196,637
|
141,806
|
104,602 |
Financial expenses |
106
|
90
|
106 |
Earnings before taxes |
50,476
|
36,439
|
21,944 |
EBITDA |
51,026
|
36,950
|
22,482 |
Total assets |
105,140
|
69,546
|
42,025 |
Current assets |
101,833
|
68,283
|
40,910 |
Current liabilities |
41,472
|
28,126
|
18,303 |
Equity capital |
59,225
|
37,318
|
21,412 |
- share capital |
65
|
60
|
63 |
Employees (average) |
71
|
61
|
55 |
Financial ratios
Fiscal year | 2023/11 | 2022/11 | 2021/11 |
Solvency |
56.3%
|
53.7%
|
51.0% |
Turnover per employee |
2,770
|
2,325
|
1,902 |
Profit as a percentage of turnover |
25.7%
![]() |
25.7%
|
21.0% |
Return on assets (ROA) |
48.1%
|
52.5%
![]() |
52.5% |
Current ratio |
245.5%
|
242.8%
|
223.5% |
Return on equity (ROE) |
85.2%
|
97.6%
|
102.5% |
Change turnover |
43,035
|
42,797
|
13,597 |
Change turnover % |
28%
|
43%
|
15% |
Chg. No. of employees |
10
|
6
|
13 |
Chg. No. of employees % |
16%
|
11%
|
31% |
Total value of public sale
Fiscal year | 2023/11 | 2022/11 | 2021/11 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.